Director Zhang Junping of Sanbo Brain Department won the honorary title of the eighth "Beijing Excellent Physician"

A few days ago, the Beijing Physician Association announced the eighth Beijing Excellent Physician commendation and decision, and 161 physicians received this honor. Among them, Zhang Junping, director of the Department of Neuroma Chemotherapy of Sanbo Brain Hospital of the Capital Medical University, won the title of "Beijing Excellent Physician".

Zhang Junping, chief physician, master's tutor, doctorate in oncology, doctorate in neuromaic tumor chemotherapy, director of the Department of Neuroma Chemotherapy at the Sanbo Brain Hospital of the Capital Medical University, and a scholar at the Dana-Farber Oncology Center of Harvard University. He is currently the deputy chairman of the China Anti -Cancer Association's neuroma professional committee, the chairman of the Youth Committee of the Beijing Anti -Cancer Association Neuroma Special Committee, and the secretary and executive member of the Beijing Anti -Cancer Association Neuroma Special Committee.

The explorer climbed the peak, and the persistent person moved forward. Since 18 years of medical treatment, Director Zhang Junping has been committed to the clinical, scientific research and teaching work of neuroma tumor chemotherapy, and has made outstanding contributions to the research, development and development of neurotoma chemotherapy, and the clinical trials of neuromaic tumor chemotherapy. Come to hope.

Fill in domestic brain tumor chemotherapy gaps and benefit 17,000 patients with sub -tumor patients

Brain tumors are interdisciplinary disciplines of neuroscience and oncology, which are different from the body tumor. The brain tumor is the first in the incidence of children's physical tumors and is the tumor with the highest mortality rate of children. The highest incidence of adult malignant brain tumors is glioma, which is more common in young adults and high residual rates for death. 18 years ago, there were no professionals in China who were specializing in brain tumor chemotherapy.

In 2004, after graduating from Dr. Zhang Junping's Dr. Oncology, he abandoned the opportunities for direct employment of well -known large hospitals. He chose to continue to be a post -doctoral post -doctoral chemotherapy work in the country at that time, and few people were involved in. The need for patients to treat Zhang Junping has never left the field of neuroma chemotherapy.

After 18 years of cultivation and persistence of Director Zhang Junping: neuromaic chemotherapy has never been recognized, and now generally receiving chemotherapy is an indispensable part of comprehensive treatment of malignant neuroma; 8 -person team; there are more than a few medicines that can use more than ten clinical new drugs in Kerry; from more than ten patients per month a month ago, more than 300 patients were discharged from the hospital for more than 300 per month. A total of more than 17,000 patients with brain tumors and spinal cord tumors have been diagnosed with a total of 32 provinces and regions across the country, bringing hope to countless families.

Director Zhang Junping has won the title of "2016 Excellent Young Doctor in 2016" because of his contribution to medical education and research. On the occasion of the 100 -year party, it was selected as an excellent Communist Party member of the Sanbo Brain Hospital of the Capital Medical University as a representative.

Courage to explore, continue to innovate, practice and promote the standardized diagnosis and treatment of brain tumors

Clinically, chemotherapy drugs are one of the weapons for patients with neuroma. At that time, when Director Zhang Junping began to engage in neuromaic chemotherapy, he faced the problem of treating a few drugs in the treatment of brain tumor chemotherapy and lack of effective chemotherapy schemes. In order to break through the predicament, Director Zhang Junping conducted a wide range of investigations, actively explored, courageous innovation, conducted clinical trials of drugs, presided over more than ten clinical research, and published more than 20 papers.

Director Zhang Junping's first reorganized human vascular endothelial inhibitoryin combined with olizolid and Yiliidan provided a effective chemotherapy plan for the governance reclutable maternal cytoma; The reaction rate increased from 50%to 80%; the earliest research on targeted drugs Apatinib the treatment of high -level glue tumors in adults, and research results were reported orally at the annual conference of neuroplasma. Not only does it solve the problem of lack of effective chemotherapy schemes for patients with brain tumors, but also contributes Chinese forces to neuroma treatment.

Director Zhang Junping knows that the strength of a person and a team is limited. In order to benefit more patients with brain tumor, Director Zhang Junping also devoted many energy to academic lectures, practiced physical strength, and promoted the standardized diagnosis and treatment of brain tumors.

Director Zhang Junping promoted the standardized diagnosis and treatment of neuromotrans on academic conferences, seminars, Sanbo Brain Hospital and foreign hospitals through neurosurgery and neuroma -related professional academic conferences, seminars, Sanbo Brain Hospital and Foreign Hospitals. The report report on the next meeting/lectures 40 ~ 50 times. Symposiums are held every year, focusing on glue tumors, marrow female celloma, reproductive cell tumors, children's brain tumors, new pathological classifications, etc., convey international cutting -edge dynamics, gather "diagnosis" to "cure", and improve the level of diagnosis and treatment of young doctors. Promoting the popularization of neuromanological diagnosis and treatment will help reduce the unevenness of the level of diagnosis and treatment technology, thereby benefiting more patients.

In addition, as a popular science expert on the Beijing Health and Health Commission, Director Zhang Junping also promoted the knowledge of neuroplasit chemotherapy through expert interviews, live broadcast live broadcasts, writing popular science articles, and recording science popularization videos. Essence

Choose one thing for a lifetime, and the end of life. Director Zhang Junping adheres to his original intention, persistent focus, concentrate on learning, enthusiastic about public welfare, 18 years of cultivation and persistence, just to allow more neuroma patients to get better medical services and continue to move forward!

- END -